Medical Facilities Corporation
DR.TOTSXHealthcare● Active
$18.51
+$0.58(+3.23%)
Market Cap$324855109
P/E Ratio—
52W High$18.79
52W Low$13.59
Medical Facilities Corporation (DR.TO) Earnings: Dates, EPS & Revenue History
Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.
DR.TO · earnings · updated Jun 8, 2026
Latest Earnings
Q2 FY2026Report Date: May 7, 2026EPS Actual
$0.29
Est. $1.96 · -85.1%
Revenue
$0.09B
Est. $0.09B · +8.9%
Fiscal Period
Q2 FY2026
FY ends December
Report Date
May 7, 2026
After Market Close
▼ Miss EPS▲ Beat Revenue
DR.TO reports quarterly as a TSX-listed Medical - Care Facilities company. Fiscal year ends in December. Data: FMP · Updated hourly.
Next Earnings Date
Days Away
85
days
Expected Date
Sep 1, 2026
Fiscal Period
Q3 FY2026
Release Time
◌ Time TBD (Unconfirmed)EPS Est.
$0.37
Rev. $0.36B
Days Away85
Expected DateSep 1, 2026
Fiscal PeriodQ3 FY2026
Release TimeTime TBD (Unconfirmed)
EPS Est.$0.37
Rev. Est.$0.36B
EPS & Revenue vs. Estimates
Actual (Beat)
Actual (Miss)
Estimated
Earnings History
| Period | Report Date | EPS Est. | EPS Actual | EPS Surpr. | Revenue | Rev. Est. | Rev. Surpr. |
|---|---|---|---|---|---|---|---|
| ◌ Q3 FY2026 | Aug 6, 2026 | $0.25 | — | — | — | $0.09B | — |
| ▼ Q2 FY2026 | May 7, 2026 | $1.96 | $0.29 | -85.1% | $0.09B | $0.09B | +8.9% |
| ▼ Q1 FY2026 | Mar 12, 2026 | $0.48 | $0.21 | -57.1% | $0.13B | $0.11B | +18.6% |
| ▼ Q4 FY2025 | Nov 6, 2025 | $0.38 | $0.32 | -14.8% | $0.11B | $0.11B | +5.2% |
| ▲ Q3 FY2025 | Aug 7, 2025 | $0.21 | $0.31 | +45.5% | $0.11B | $0.08B | +39.5% |
| ▼ Q2 FY2025 | May 7, 2025 | $0.22 | $0.17 | -22.7% | $0.12B | $0.08B | +40.5% |
| ▲ Q1 FY2025 | Mar 12, 2025 | $0.50 | $0.59 | +18.0% | $0.02B | $0.08B | -78.2% |
| ▼ Q4 FY2024 | Nov 7, 2024 | $0.50 | $0.30 | -40.0% | $0.14B | $0.14B | -1.7% |
Q3 FY2026
Aug 6, 2026
EPS Actual
—
EPS Est.
$0.25
EPS Surpr.
—
Revenue
—
Q2 FY2026
May 7, 2026Miss
EPS Actual
$0.29
EPS Est.
$1.96
EPS Surpr.
-85.1%
Revenue
$0.09B
Q1 FY2026
Mar 12, 2026Miss
EPS Actual
$0.21
EPS Est.
$0.48
EPS Surpr.
-57.1%
Revenue
$0.13B
Q4 FY2025
Nov 6, 2025Miss
EPS Actual
$0.32
EPS Est.
$0.38
EPS Surpr.
-14.8%
Revenue
$0.11B
Q3 FY2025
Aug 7, 2025Beat
EPS Actual
$0.31
EPS Est.
$0.21
EPS Surpr.
+45.5%
Revenue
$0.11B
Q2 FY2025
May 7, 2025Miss
EPS Actual
$0.17
EPS Est.
$0.22
EPS Surpr.
-22.7%
Revenue
$0.12B
Q1 FY2025
Mar 12, 2025Beat
EPS Actual
$0.59
EPS Est.
$0.50
EPS Surpr.
+18.0%
Revenue
$0.02B
Q4 FY2024
Nov 7, 2024Miss
EPS Actual
$0.30
EPS Est.
$0.50
EPS Surpr.
-40.0%
Revenue
$0.14B
Analyst Estimates
Limited analyst coverage (fewer than 3 analysts). Estimates may not reflect market consensus.
EPS Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2026 | $0.30 | $0.30 | $0.30 | 1 |
| Q3 FY2026 | $0.15 | $0.15 | $0.15 | 1 |
| Q2 FY2026 | $0.18 | $0.18 | $0.18 | 1 |
| Q1 FY2026 | $1.41 | $1.41 | $1.41 | 1 |
| Q4 FY2025 | $0.35 | $0.35 | $0.35 | 1 |
| Q3 FY2025 | $0.27 | $0.27 | $0.27 | 1 |
Revenue Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2026 | $0.1B | $0.1B | $0.1B | 1 |
| Q3 FY2026 | $0.1B | $0.1B | $0.1B | 1 |
| Q2 FY2026 | $0.1B | $0.1B | $0.1B | 1 |
| Q1 FY2026 | $0.1B | $0.1B | $0.1B | 1 |
| Q4 FY2025 | $0.1B | $0.1B | $0.1B | 2 |
| Q3 FY2025 | $0.1B | $0.1B | $0.1B | 1 |
Earnings Price Reaction
Closing price one trading day before vs. one trading day after each earnings release.
| Period | Report Date | EPS Beat/Miss | Price Before | Price After | 1D Reaction |
|---|---|---|---|---|---|
| ▼ Q2 FY2026 | May 7, 2026 | -85.1% | $16.96 | $16.90 | -0.35% |
| ▼ Q1 FY2026 | Mar 12, 2026 | -57.1% | $17.42 | $16.60 | -4.71% |
| ▼ Q4 FY2025 | Nov 6, 2025 | -14.8% | $13.79 | $14.55 | +5.51% |
| ▲ Q3 FY2025 | Aug 7, 2025 | +45.5% | $14.99 | $14.29 | -4.67% |
| ▼ Q2 FY2025 | May 7, 2025 | -22.7% | $14.81 | $15.16 | +2.36% |
| ▲ Q1 FY2025 | Mar 12, 2025 | +18.0% | $17.31 | $16.83 | -2.77% |
| ▼ Q4 FY2024 | Nov 7, 2024 | -40.0% | $14.68 | $14.68 | +0.00% |
| ▼ Q3 FY2024 | Aug 6, 2024 | -106.7% | No price data | $13.54 | — |
Q2 FY2026-0.35%
Report Date
May 7, 2026
EPS Beat/Miss
-85.1%
Price Before
$16.96
Price After
$16.90
Q1 FY2026-4.71%
Report Date
Mar 12, 2026
EPS Beat/Miss
-57.1%
Price Before
$17.42
Price After
$16.60
Q4 FY2025+5.51%
Report Date
Nov 6, 2025
EPS Beat/Miss
-14.8%
Price Before
$13.79
Price After
$14.55
Q3 FY2025-4.67%
Report Date
Aug 7, 2025
EPS Beat/Miss
+45.5%
Price Before
$14.99
Price After
$14.29
Q2 FY2025+2.36%
Report Date
May 7, 2025
EPS Beat/Miss
-22.7%
Price Before
$14.81
Price After
$15.16
Q1 FY2025-2.77%
Report Date
Mar 12, 2025
EPS Beat/Miss
+18.0%
Price Before
$17.31
Price After
$16.83
Q4 FY2024+0.00%
Report Date
Nov 7, 2024
EPS Beat/Miss
-40.0%
Price Before
$14.68
Price After
$14.68
Q3 FY2024—
Report Date
Aug 6, 2024
EPS Beat/Miss
-106.7%
Price Before
—
Price After
$13.54
Avg Beat Reaction-3.72%
Avg Miss Reaction+0.56%
Beat Rate2 / 8 quarters
Largest Move+5.51% (Q4 FY2025)
Data: FMP /historical-price-eod/full · field: close
About Earnings & Data Methodology
Data source: Financial Modeling Prep (FMP) | Updated: Hourly | Surprise%: (Actual − Estimate) / |Estimate| × 100 | Fiscal year: DR.TO ends December
Medical Facilities Corporation (DR.TO) most recently reported earnings on May 7, 2026 for Q2 FY2026, posting EPS of $0.29 — missing the analyst consensus of $1.96 by -85.1%. The next DR.TO earnings date is expected around September 1, 2026.
Each quarter, investors track DR.TO earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. DR.TO revenue tab →
Earnings Glossary
EPS (Earnings Per Share)
Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.
Earnings Surprise %
(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.
Beat / Miss / In-Line
Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.
BMO / AMC
Before Market Open / After Market Close. Two windows when companies typically release results.
Fiscal Quarter
DR.TO's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.
Analyst Consensus
Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.
Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.
Frequently asked questions
DR.TO earnings · 5 questionsMedical Facilities Corporation's next earnings report is expected around September 1, 2026. DR.TO typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; DR.TO historically reports after market close (AMC).
DR.TO earnings datewhen is DR.TO earningsDR.TO next earnings datewhen does DR.TO report earningsDR.TO earnings calendar
▸ Source: FMP · Medical Facilities Corporation SEC filings · US GAAP · Medical Facilities Corporation SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 8, 2026